t(6;11)(q15;q23) KMT2A/?

2009-03-01   Jong Rak Choi  , Tae Sung Park  

1.Department of Laboratory Medicine, Kyung Hee University College of Medicine, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-702, Korea (TSP); Department of Laboratory Medicine, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul 120-752, Korea (JRC)

Clinics and Pathology

Note

Only 4 cases to date, 3 of which do not provide further descriptions.

Phenotype stem cell origin

All cases were acute myeloid leukaemia (AML); AML-M0 (1 case), AML-M2 (1 case), AML-M4 (2 cases).

Epidemiology

All patients were female between the ages of 13 to 68 years.
Atlas Image
Multi-color FISH image showing t(6;11)(q15;q23).
Atlas Image
Bone marrow morphology from AML-M2 case with t(6;11)(q15;q23).

Prognosis

Very poor in 1 case (survival : only 2 weeks in AML-M2).

Cytogenetics

Cytogenetics morphological

It shows distinct balanced chromosomal abnormalities between chromosomes 6 and 11; however, it should be differentiated from t(6;11)(q13;q23) in association with MLL/ SMAP1 rearrangement.

Cytogenetics molecular

MLL breakapart FISH probe is very useful.

Additional anomalies

del(5)(q13q15) in 1 case, sole abnormality in remaining 3 cases.

Genes Involved and Proteins

Note
The gene involved in 6q15 is unknown.
Gene name
KMT2A (myeloid/lymphoid or mixed lineage leukemia)
Location
11q23.3
Note
More than 50 different translocation fusion partners in association with the MLL gene have been reported in the literature. In chromosome 6, t(6;11)(q27;q23) (MLL/AF6 rearrangement) is the most commonly encountered chromosomal abnormality. In contrast, t(6;11)(q13;q23) or t(6;11)(q15;q23) is the rarest type of MLL rearrangement involving the long arm of chromosome 6.

Result of the Chromosomal Anomaly

Note

Unknown. However, MLL/SMAP1 rearrangement was excluded in one case by both our group and Dr. Meyer.Unknown.

Highly cited references

Pubmed IDYearTitleCitations
413503602025Dysregulation of HOXA genes in acute myeloid leukemia and targeted therapy.214
398877302026Targeting the Menin-KMT2A interaction in leukemia: Lessons learned and future directions.129
369798002023Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia.111
353280682022KMT2A: Umbrella Gene for Multiple Diseases.104
366355032023Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes.102
411924222025Disparate leukemia mutations converge on nuclear phase-separated condensates.98
393039152024Histone methyltransferase KMT2A: Developmental regulation to oncogenic transformation.94
395946992024Targeting Menin in Acute Myeloid Leukemia: Therapeutic Advances and Future Directions.94
403612412025Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies.86
394755092024NUP98 fusion proteins and KMT2A-MENIN antagonize PRC1.1 to drive gene expression in AML.83
388889672024KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma.83
409566182025In utero rescue of neurological dysfunction in a mouse model of Wiedemann-Steiner syndrome.83
405017352025Nuclear Phase Separation Drives NPM1-mutant Acute Myeloid Leukemia.83
377886692023Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement.81
388890072024An enhancer RNA recruits KMT2A to regulate transcription of Myb.80
412798182025ZMYND11 Restrains KMT2A to Enable a Neuronal Developmental Program.80
386125312024Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities.79
370199902023The KMT2A recombinome of acute leukemias in 2023.76
410625062025The genomic landscape of relapsed infant and childhood KMT2A-rearranged acute leukemia.74
417498902026Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision Care.74
378913682023SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.74
370199722023Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.71
367818502023Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia.68
393800022024The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency.68
366290172023DNA fragility at the KMT2A/MLL locus: insights from old and new technologies.67
396822032024Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin Inhibitor.62
377097462023KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics.61
392017092024KMT2A Rearrangements in Leukemias: Molecular Aspects and Therapeutic Perspectives.60
370369702023Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens.60
335424822021Menin is necessary for long term maintenance of meningioma-1 driven leukemia.58
395725322024KMT2A regulates the autophagy-GATA4 axis through METTL3-mediated m(6)A modification of ATG4a to promote NPCs senescence and IVDD progression.57
346639242021Automated CUT&Tag profiling of chromatin heterogeneity in mixed-lineage leukemia.57
364799092023KMT2A-D pathogenicity, prevalence, and variation according to a population database.57
361816132022Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A.57
371008822023The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome.57
407296812025Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients.55
406461352025Ontogeny-specific induction of the KMT2A::AFF1-fusion drives development of a distinct CD24 positive pre-leukemic state.55
397041472025Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia.50
348649162022Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia.49
380498292023Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.49
345506332022KMT2A-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.49
398882752025Histone methyltransferase KMT2A promotes pulmonary fibrogenesis via targeting pro-fibrotic factor PU.1 in fibroblasts.46
324368622020KMT2A regulates cervical cancer cell growth through targeting VDAC1.45
406722742025Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy Strategy.44
340482752021Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531.43
389056352024Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias.40
390863072024Revumenib for patients with acute leukemia: a new tool for differentiation therapy.40
380255232023KMT2A maintains stemness of gastric cancer cells through regulating Wnt/β-catenin signaling-activated transcriptional factor KLF11.40
418492342026Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models.39
362136382022Clinical profile in KMT2A-SEPT6-positive acute myeloid leukemia: Does it often co-occur with NRAS mutations?37
386212002024Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.35
242911272014Diverse functions of PHD fingers of the MLL/KMT2 subfamily.33
397660922024Detection of KMT2A Partial Tandem Duplication by Optical Genome Mapping in Myeloid Neoplasms: Associated Cytogenetics, Gene Mutations, Treatment Responses, and Patient Outcomes.33
369225932023The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.31
376491042023A de novo mutation of ADAMTS8 in a patient with Wiedemann-Steiner syndrome.27
378132992023Droplet Digital PCR for Oncogenic KMT2A Fusion Detection.26
315927982020Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.25
408792542025YAP1::KMT2A-Rearranged Sarcoma: Report of a New Case With Unusual Morphology and Immunohistochemical Features.22
326115752020NUP98 and KMT2A: usually the bride rather than the bridesmaid.21
363521922023Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma.14
355843762022Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes.13
392646142024A menin-KMT2A inhibitor to overcome resistance.10
411214462025KMT2A alterations in acute myeloid leukemia: a proposed genetic risk model and transplantation outcomes.10
392809862024Pitfalls in Diagnosis: JMML versus KMT2A Rearranged Juvenile AML.10
341480652021Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.10
405014112025Metabolic epigenome targeting hits KMT2A-rearranged acute lymphoblastic leukemia.9
363953132022Infant Leukemia.0
379951052023Unraveling KMT2A-rearranged ALL.0
363016332022KMT2A-rearranged leukemia: the shapeshifter.0
416532482026Ziftomenib: First Approval.0
400727752025Revumenib: First Approval.0
369912592023Menin-KMT2A interaction inhibitor shows promise.0
404414662025Menin inhibitors in KMT2A-rearranged and NPM1-mutated acute leukemia: A scoping review of safety and efficacy.0
369640332023KMT2A amplification in B lymphoblastic leukaemia.0
357160192022Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry.0
412314562025Mantle cell lymphoma with KMT2A rearrangement.0
411447592026Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML.0
410338522025Infant acute lymphoblastic leukaemia-Progress from worldwide clinical efforts.0
377123892024A novel KMT2A::DCP1B rearrangement in chronic neutrophilic leukemia.0
407687512025Induction chemotherapy and molecular MRD influence outcomes in KMT2A-rearranged AML.0
375750842023VIM::KMT2A rearranged sarcoma: a rare emerging entity.0
333140532021Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.0
382348542024KMT2A oncoproteins induce epigenetic resistance to targeted therapies.0
369302602023Sustained spontaneous remission in KMT2A-MLLT3 mutated myeloid sarcoma.0
307074742019Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.0
359339462022KMT2A-CBL fusion in rapidly progressive myeloid disorder.0
387105952024The Menin story in acute myeloid leukaemia-The road to success.0
407495822025Menin inhibitors in KMT2A-rearranged leukemia: Mechanistic insights, clinical trial progress, and potential of combination therapies.0
364413562023Evolution and optimization of therapies for acute lymphoblastic leukemia in infants.0
389557142024[YAP1-KMT2A fused sarcoma: report of a case].0
372481682023Acute monocytic leukemia with KMT2A:MLLT10 transformed to AML-M7 in a pediatric patient.0
251313042015MLL/KMT2A translocations in diffuse large B-cell lymphomas.0
343247642022Acute lymphoblastic leukemia in infants: A quarter century of nationwide efforts in Japan.0
395796122025Ailanthone targets the KMT2A-MEN1 complex to suppress lung metastasis of osteosarcoma.0
423187772026KMT2A and KMT2B episignatures address diagnostic challenges associated with rare neurodevelopmental disorders.0
287235592017KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions.0
385209572024Raman spectroscopy can recognize the KMT2A rearrangement as a distinct subtype of leukemia.0
409443462025LDB1::KMT2A Fusion in a Spindle-Cell Sarcoma: A Case Report.0
317107782020Wiedemann-Steiner syndrome in two patients from Portugal.0
252843272015The epigenetic factor Kmt2a/Mll1 regulates neural progenitor proliferation and neuronal and glial differentiation.0

Article Bibliography

Pubmed IDLast YearTitleAuthors
156267572005Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.Meyer C et al
189833032008Comparison of multiplex reverse transcription polymerase chain reaction and conventional cytogenetics as a diagnostic strategy for acute leukemia.Park JS et al
189926432008MLL rearrangement with t(6;11)(q15;q23) as a sole abnormality in a patient with de novo acute myeloid leukemia: conventional cytogenetics, FISH, and multicolor FISH analyses for detection of rare MLL-related chromosome abnormalities.Park TS et al
159213752005Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).Sinclair P et al
81238531994Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).Stasi R et al

Summary

Atlas Image
Giemsa-banding partial karyograms of t(6;11)(q15;q23). (Each left side chromosomes 6 and 11: normal, each right side chromosomes 6 and 11: derivative chromosome).

Citation

Jong Rak Choi ; Tae Sung Park

t(6;11)(q15;q23) KMT2A/?

Atlas Genet Cytogenet Oncol Haematol. 2009-03-01

Online version: http://atlasgeneticsoncology.org/haematological/1522/t(6